Table 4 Comparison of clinicopathological characteristics between two groups stratified by CA 19–9 level
From: Diagnostic and prognostic value of CEA, CA19–9, AFP and CA125 for early gastric cancer
Characteristics | CA19–9(−) | CA19–9(+) | P |
|---|---|---|---|
Gender | |||
Male | 428 | 16 | 0.025 |
Female | 131 | 12 | |
Age | |||
≤ 60 | 351 | 17 | 0.843 |
> 60 | 208 | 11 | |
Tumor location | |||
Upper third | 95 | 7 | 0.543 |
Middle third | 96 | 4 | |
Lower third | 368 | 17 | |
Tumor size (cm) | |||
≤ 2 | 345 | 20 | 0.327 |
> 2 | 214 | 8 | |
Pathological type | |||
Well differentiated | 178 | 8 | 0.936 |
Moderately differentiated | 156 | 7 | |
Poorly differentiated | 208 | 12 | |
Signet ring cell or Mucinous | 17 | 1 | |
Tumor depth | |||
T1a | 243 | 12 | 1.000 |
T1b | 316 | 16 | |
Lymph node metastasis | |||
N0 | 475 | 20 | 0.020 |
N1 | 52 | 3 | |
N2 | 26 | 3 | |
N3 | 6 | 2 | |